Abbott has issued a recall for select HeartMate mobile power units used with its HeartMate3 and HeartMate III left-ventricular assist systems due to risk of sudden power loss that could lead to serious injury or death. The recall affects power…
Supply Chain
Though Boston Scientific brought in $4.66 billion in revenue for the first quarter of 2025, up 20.9% year over year, the medical devicemaker is bracing for a potential $200 million hit in the second half of the year stemming from…
A growing number of pharmaceutical companies are sharing plans to ramp up domestic manufacturing capacity amid recent tariffs imposed by the Trump administration. Here are five things to know:
DHL Express announced a temporary suspension of business-to-consumer shipments valued over $800 to private individuals in the U.S., effective April 21. The move is in response to the new U.S. Customs and Border Protection regulations that reduce the threshold for…
The FDA has issued a safety warning regarding a potentially high-risk issue involving certain BD PowerPICC Intravascular Catheters. The affected devices are 4 Fr. Single Lumen PowerPICC catheters, both SOLO and non-SOLO versions, manufactured by BD and its subsidiary Bard…
Advertisement
Abbott Laboratories announced a plan to invest $500 million to expand its U.S. manufacturing footprint. The medical device maker will upgrade facilities in both Illinois and Texas to expand its existing plants and boost research and development for its transfusion…
In the face of persistent disruptions across supply chains, health systems across the country are making strides to help strengthen resilience, ensure continual care and build agile, responsive operations. Below are responses from seven supply chain leaders who were asked:…
President Donald Trump has threatened tariffs on pharmaceutical imports, with U.S. Commerce Secretary Howard Lutnick confirming that the tariffs will be implemented “in a month or two,” ABC News reported April 13. “Semiconductors and pharmaceuticals will have a tariff model…
China imposed 125% tariffs on U.S. goods in retaliation to President Donald Trump imposing a 145% tariff rate on Chinese goods, NPR reported April 11. China’s finance ministry said no additional measures will follow: “If the U.S. continues to increase…
Novartis plans to invest $23 billion over the next five years to expand its manufacturing and research in the U.S. The investment will cover more than 10 facilities, including seven new sites, and will enable the drugmaker to produce its…